Session Details

F047 Autoimmune Blistering Diseases: What's New?

Sun, Mar 21, 1:00 PM - 3:00 PM
2 CME Available Forum

DESCRIPTION

This session will focus on new advances in AIBD regarding the current treatments and treatments in trials for pemphigus, bullous pemphigoid, mucous membrane pemphigoid and EBA, along with how these may change the way these conditions are managed.

LEARNING OBJECTIVES

1.

Discuss the evidence behind rituximab for pemphigus and other conditions and what to do if that fails

2.

Discuss the evidence behind dupilumab for bullous pemphigoid and treatments in trials for BP

3.

Discuss the current and potential new treatments in trials for MMP and EBA

SCHEDULE

1:00 PM

Introduction to What's New in AIBD

Dedee F. Murrell, MD, FAAD

1:05 PM

What’s New in the use of Rituximab in AIBD

Pascal Joly, MD, PhD, IFAAD

1:23 PM

Other therapies for Pemphigus when rituximab fails

Victoria P. Werth, MD, FAAD

1:41 PM

Q &A on pemphigus and rituximab

Pascal Joly, MD, PhD, IFAAD, Victoria P. Werth, MD, FAAD

1:50 PM

Is Dupilumab a Game Changer for Bullous Pemphigoid

Dedee F. Murrell, MD, FAAD

2:08 PM

What is in the pipeline for BP

Aikaterini Patsatsi, MD, PhD, IFAAD

2:26 PM

What’s new in therapy for MMP & EBA

Frederic Caux, PhD

2:44 PM

Questions and Answers & closing remarks

Dedee F. Murrell, MD, FAAD, Frederic Caux, PhD, Aikaterini Patsatsi, MD, PhD, IFAAD

DIRECTOR

Dedee F. Murrell, MD, FAAD

Dedee F. Murrell, MD, FAAD

UNSW Sydney Australia

SPEAKERS

Frederic Caux, PhD

Frederic Caux, PhD

Pascal Joly, MD, PhD, IFAAD

Pascal Joly, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Aikaterini Patsatsi, MD, PhD, IFAAD

Victoria P. Werth, MD, FAAD

Victoria P. Werth, MD, FAAD

University of Pennsylvania

DISCLOSURES

Frederic Caux, PhD

arGEN-X – Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);

Pascal Joly, MD, PhD, IFAAD

AbbVie – Consultant (1099 relationship)(Fees); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); BMS – Advisory Board(Honoraria); Glycoera – Consultant (1099 relationship)(Honoraria); janssen – Advisory Board(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria); UCB – Advisory Board(Honoraria);

Dedee F. Murrell, MD, FAAD

AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Alumis – Investigator(Fees); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Fees); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Attovia Therapeutics – Investigator(Fees); Bambusa Therapeutics Inc – Advisory Board(Fees); BMS – Investigator(Fees); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Evelo Biosciences, Inc. – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Incyte – Investigator(Fees); Johnson & Johnson – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Other(No Compensation Received); L'Oreal – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Fees), Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ono – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); RAPT Therapeutics – Advisory Board(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); RHEACELL – Data Safety Monitoring Board(Fees); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); TWi Biotechnology, Inc. – Advisory Board(Fees), Investigator(Fees); UCB – Investigator(Fees); UpToDate – Other(Fees);

Aikaterini Patsatsi, MD, PhD, IFAAD

AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Innovaderm Research Inc. – Advisory Board(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Speaker(Honoraria); UCB – Speaker(Honoraria);

Victoria P. Werth, MD, FAAD

AbbVie – Consultant (1099 relationship)(Fees); Almirall – Consultant (1099 relationship)(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arionix – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Daiichi Sanko – Consultant (1099 relationship)(Honoraria); Dianthus Therapeutics – Consultant (1099 relationship)(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); First Tracks Biotherapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Innovaderm Research Inc. – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Prolium – Consultant (1099 relationship)(Honoraria); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi Aventis – Consultant(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); Valuence – Consultant (1099 relationship)(Honoraria); Vindico Medical Education – Speaker/Faculty Education(Honoraria);